Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of JZP-386 vs Xyrem in Healthy Volunteers
NCT02215499Phase 1Completed
- Sponsor
- Concert Pharmaceuticals
- Start
- Jul 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of deuterated sodium oxybate in narcolepsy (3 arms), sponsored by Concert Pharmaceuticals. Primary endpoint: Safety (Adverse Events, Vital Signs, Pulse Oximetry) at 3 days. Started Jul 2014; status: completed.
02
Drugs
deuterated sodium oxybate
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT02215499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02215499.